Subcutaneous panniculitis-like T-cell lymphoma
MONDO:0019475Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare cytotoxic cutaneous lymphoma that has been recognized as a distinct subset of peripheral T-cell lymphomas originating and presenting primarily in the subcutaneous fat tissue.
Also known as: SPTCL, subcutaneous panniculitic T-cell lymphoma, subcutaneous panniculitis-like T-cell lymphoma, subcutaneous panniculitis-like T-cell lymphoma (Alpha/Beta type), subcutaneous panniculitis-like T-cell lymphoma, Alpha/Beta type, T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE
3128 clinical trials for this condition and its sub-types, 8 tagged with Subcutaneous panniculitis-like T-cell lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Vitamin d boost may extend life in lymphoma patients, trial hopes
Disease control OngoingThis study looks at whether giving vitamin D supplements to people with newly diagnosed lymphoma or chronic lymphocytic leukemia who have low vitamin D levels can improve their survival and delay the need for treatment. About 565 participants are being given vitamin D3 or a place…
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo shows promise for rare blood cancer
Disease control OngoingThis early-stage study tested a combination of two drugs (pembrolizumab and pralatrexate) in 13 people with peripheral T-cell lymphoma that had returned or not responded to prior treatment. The goal was to find the safest dose and see if the combo could shrink tumors. The approac…
Phase 1/2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC